Gene: TMEM54
Official Full Name: transmembrane protein 54provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30834 | TMEM54 Knockout cell line (HeLa) | Human | TMEM54 | 1:3~1:6 | Negative | Online Inquiry |
KO30835 | TMEM54 Knockout cell line (HCT 116) | Human | TMEM54 | 1:2~1:4 | Negative | Online Inquiry |
KO30836 | TMEM54 Knockout cell line (HEK293) | Human | TMEM54 | 1:3~1:6 | Negative | Online Inquiry |
KO30837 | TMEM54 Knockout cell line (A549) | Human | TMEM54 | 1:3~1:4 | Negative | Online Inquiry |
TMEM54 Gene Knockout Cell Lines are specialized cellular models engineered to facilitate the study of the TMEM54 gene, which has been implicated in various biologic processes, including cellular metabolism and signaling pathways. By creating these knockout cell lines, researchers can effectively eliminate the expression of the TMEM54 gene, thereby enabling them to investigate its functional role in both normal and pathological states. This approach allows for in-depth analyses of the cellular mechanisms that underpin complex diseases, thus providing valuable insights into potential therapeutic targets.
These cell lines predominantly function through the use of CRISPR-Cas9 gene-editing technology, which creates precise genetic alterations to achieve the desired knockout effect. The resulting TMEM54-deficient cells present an unparalleled opportunity to assess the impact of this gene on cellular behaviors such as proliferation, differentiation, and response to stressors. Such research is vital not only for understanding basic biological mechanisms but also for discovering novel interventions in diseases where TMEM54 has been implicated.
In clinical and research settings, the significance of TMEM54 Gene Knockout Cell Lines extends to their utility as a platform for drug screening, biomarker discovery, and the study of gene-environment interactions. These lines can serve as a valuable resource for pharmaceutical development, as they allow for the identification of drug candidates that can specifically target pathways modulated by TMEM54.
What sets our TMEM54 Gene Knockout Cell Lines apart from alternative products is their rigorous validation and quality control. Each line is comprehensively characterized to ensure consistent performance and reproducibility in experimental applications. Furthermore, our product offering includes extensive technical support and resources, ensuring that users can fully optimize their research processes with minimal disruption.
The value of TMEM54 Gene Knockout Cell Lines to researchers and clinicians lies in their ability to further elucidate the complexities of gene function within critical biological contexts. By leveraging our expertise in cellular engineering and genetic manipulation, we provide an indispensable tool for advancing scientific discovery and improving clinical outcomes. Our commitment to quality and innovation reinforces our position as a leader in biological products, dedicated to fostering breakthroughs that have the potential to transform healthcare.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.